The next step was to analyze the distribution of the tested polymorphisms in patients with the presence or absence of RA diagnostic markers such as RF, anti-cyclic citrullinated peptide antibodies (anti-CCP), and anti-mutated citrullinated vimentin antibodies (anti-MCV) (Table 5). This evidence concerns the gene VIM and rheumatoid arthritis.